genekam logo
  • usa
    • german
    • russia
    • china
Duissernstr. 65a · 47058 Duisburg · Germany
Tel. +49 203 / 555858-31,-32,-33 · Fax: +49 203 / 35 82 99
menuicon
slider
Latest News:

21.01.2020
Genekam has developed novel corona virus 2020 (Wuhan strain specific) kits and potential therapeutic molecules.

Latest News:

21.01.2020
3D Genomemedicine Inc is going to operate in USA

  • ++BREAKING NEWS (20.01.2020)++

    Genekam has developed novel corona virus 2020 (Wuhan strain specific) kits and potential therapeutic molecules.

  • MEDICA 2020

    Visit us at MEDICA in Duesseldorf, Germany:
    16.11. - 19.11.20

  • BIO 2020

    Visit us at BIO 2020 in San Diego, USA:
    08.06. - 11.06.2020

  • New Distributor in the U.S.A.

    MTC Industries Inc. from New York State is distributor for Genekam products and Coronavirus solutions
    Tel: 001-631-2734-4818 Ext 118

T-cell immunotherapy solution - car T-cell therapy

There are many laboratories developing CAR T-cell therapies. Genekam has a number of kits to develop CAR T-Cell therapy e.g. isolate large number of T cells (CD4 / CD8) from blood or other source. This isolation kit will generate larger number of needed T cells against number of cells generated through density gradient methods (also called Ficolle), Magnetic beads based Kits are for separation of wanted T cells from other unwanted cells. After that they can be stimulated or undergo the cloning with specific vectors carrying specific sequences. Genekam has developed a kit, which can remove the unwanted erythrocytes, which may be disturbing factors during the development. This can accelerate the development of CAR T-cells therapies against any possible target in field oncology, virology or transplantation medicine. These kits help to make therapies economically.
TOP